The Global Adenovirus Diagnostic Testing Market Analysis , Growth , Region & Forecast Period

 Adenovirus is a type of DNA virus that is thought to be the leading cause of fever diseases in children. Adenovirus infection is more likely in people and children with persistent respiratory problems, heart disease, or weakened immune systems. The majority of adenovirus infections, on the other hand, are not life-threatening. Adenovirus is a contagious infection because it is an airborne disease that spreads through sneezing, coughing, and close contact from an infected person to others. Adenovirus can cause pneumonia, epidemic keratoconjunctivitis, gastroenteritis, acute follicular conjunctivitis, and cystitis, among other things. Pharyngitis fever and pharyngeal-conjunctivitis are the most common infections in children. Adenovirus is the second most frequent respiratory virus that causes pneumonia, according to a study undertaken by the Barcelona Center for International Health Research and the University of Barcelona in 2016. Adenoviruses can also spread through the feces of an infected person. Adenovirus can also be transmitted by water, such as swimming pools, but this is uncommon. Adenovirus infection is commonly diagnosed or detected by molecular approaches, such as serology, polymerase chain reaction (PCR), viral culture, or antigen detection. Liposomes, chromatography, monoclonal antibodies, gel microdroplets, and flow cytometry are among the new technologies that are being used to diagnose adenovirus infection.

 

Identifying the most appropriate treatment for an adenovirus infection is critical to make a prognosis and begin a treatment approach to control the infection with the use of precise antiviral medicines. As a result, the worldwide adenovirus diagnostics market is predicted to rise at a faster rate. Because the virus replicates quickly in cell cultures, adenovirus infections were formerly identified using cell culture. Adenovirus DNA detection and amplification using various PCR methods is becoming one of the most generally acknowledged laboratory approaches for detecting adenovirus infection. The rapid detection and quantification of viral DNA, particularly using techniques like PCR, is predicted to aid in the diagnosis and treatment monitoring of adenovirus infections, especially in immunocompromised patients. As a result, the worldwide adenovirus diagnostic market is predicted to rise at a faster rate during the forecast period.

The global market for viral diagnostics can be divided into two categories: diagnostic method and end-user. Viral culture, polymerase chain reaction assays and antigen-based assays, monoclonal antibodies, liposomes and flow cytometry, chromatography, and gel microdroplets are the diagnostic methods used in the adenovirus diagnostics market. Hospitals, private diagnostic laboratories, small clinics, and public health laboratories are the end-users in the global adenovirus diagnostics market.

Because of the rising incidence of the infection and the big population in Asia Pacific, the adenovirus diagnostics market is predicted to grow at a quick rate. In Africa, where a substantial proportion of children infected with adenovirus are underserved, the adenovirus diagnostic market is predicted to grow.

Agilent Technologies, Beckman Coulter/Danaher, Becton, Dickinson, and Company, Affymetrix, Bio-Rad, Roche, Novartis AG, Gen-Probe, Qiagen, Abbott, DiaSorin, and bioMerieux is among the leading companies in the global adenovirus diagnostics industry.